clinical trial · NCT00844415
Safety and Tolerability of Dabigatran Etexilate in Adolescents
Boehringer Ingelheim·phase2·completed·n = 9
Venous Thromboembolismdabigatran etexilate
brief summary
To investigate the safety and tolerability of dabigatran etexilate capsules in a small group of eight adolescent patients.
started
Jun 1, 2009
primary completion
Feb 1, 2012
completion
—
last updated
Feb 12, 2025
official title
Open-label Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given for 3 Days at the End of Standard Anticoagulant Therapy in Children Aged 12 Years to Less Than 18 Years
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol